Bank of New York Mellon Corp

Bank

Position in AVTX — Avalo Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in AVTX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,897,025

+$1,872,869 QoQ

Shares Held

102,653

+603741.2% QoQ

Ownership

0.191%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#68

of 126 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. AVTX ranks #153 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,672,623	$830,842,010
2	REGN	Regeneron Pharmaceuticals, Inc.	758,492	$472,950,091
3	JAZZ	Jazz Pharmaceuticals plc	1,578,013	$380,253,782
4	ALNY	Alnylam Pharmaceuticals, Inc.	492,071	$148,128,128
5	INSM	INSMED Inc	1,312,756	$139,966,036
6	MRNA	Moderna, Inc.	1,701,675	$119,168,293
7	RVMD	Revolution Medicines, Inc.	601,056	$112,565,759
8	INCY	Incyte Corp	972,825	$110,279,435

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,897,025	102,653	+112.5%	Shares	Defined	2026-08-06
2022-06-30	$24,156	48,313	-70.1%	Shares	Defined	2022-08-15
2022-03-31	$117,026	161,417	0.0%	Shares	Defined	2022-05-11
2021-12-31	$274,408	161,417	+2.0%	Shares	Defined	2022-02-11
2021-09-30	$345,104	158,305	—	Shares	Defined	2021-11-18
2021-06-30 CERC	—	146,813	+14.2%	Shares	Defined	2021-08-11
2021-03-31 CERC	—	128,569	+12.8%	Shares	Defined	2021-05-13
2020-12-31 CERC	—	113,945	+44.2%	Shares	Defined	2021-02-09
2020-09-30 CERC	—	79,013	+4.7%	Shares	Defined	2020-11-12
2020-06-30 CERC	—	75,495	+29.9%	Shares	Defined	2020-08-12
2020-03-31 CERC	—	58,102	—	Shares	Defined	2020-05-06
No filing history on record for this holder in this stock.